Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Nature Medicine|July 4, 2018
Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapyCarsten Krieg, Malgorzata Nowicka, Silvia Guglietta, et al.
Cellular and Molecular Life Sciences : CMLS|February 14, 2024
Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serumEvelyn Lattmann, Luca Räss, Marco Tognetti, et al.
Melanoma Research|January 19, 2017
Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?Silvia A Haueis, Pascale Kränzlin, Joanna Mangana, et al.
The Journal of Investigative Dermatology|September 29, 2022
The p300/CBP Inhibitor A485 Normalizes Psoriatic Fibroblast Gene Expression In Vitro and Reduces Psoriasis-Like Skin Inflammation In VivoJihye Kim, Yuliang He, Sabrina Tormen, et al.
Melanoma Research|December 21, 2023
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanomaNatalia M Roshardt Prieto, Patrick Turko, Caroline Zellweger, et al.
The Journal of Investigative Dermatology|March 12, 2013
Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switchingDaniel S Widmer, Keith S Hoek, Phil F Cheng, et al.
Cancers|February 11, 2023
P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant MelanomaIshani Banik, Adhideb Ghosh, Erin Beebe, et al.
Nature Communications|October 14, 2023
Androgen receptor is a determinant of melanoma targeted drug resistanceAnastasia Samarkina, Markus Kirolos Youssef, Paola Ostano, et al.
Science (New York, N.Y.)|April 21, 2007
An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plantsHongchang Cui, Mitchell P Levesque, Teva Vernoux, et al.
The Journal of Clinical Investigation|May 1, 2019
SMAD signaling promotes melanoma metastasis independently of phenotype switchingEylul Tuncer, Raquel R Calçada, Daniel Zingg, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Nature Medicine|July 4, 2018
Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapyCarsten Krieg, Malgorzata Nowicka, Silvia Guglietta, et al.
Cellular and Molecular Life Sciences : CMLS|February 14, 2024
Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serumEvelyn Lattmann, Luca Räss, Marco Tognetti, et al.
Melanoma Research|January 19, 2017
Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?Silvia A Haueis, Pascale Kränzlin, Joanna Mangana, et al.
The Journal of Investigative Dermatology|September 29, 2022
The p300/CBP Inhibitor A485 Normalizes Psoriatic Fibroblast Gene Expression In Vitro and Reduces Psoriasis-Like Skin Inflammation In VivoJihye Kim, Yuliang He, Sabrina Tormen, et al.
Melanoma Research|December 21, 2023
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanomaNatalia M Roshardt Prieto, Patrick Turko, Caroline Zellweger, et al.
The Journal of Investigative Dermatology|March 12, 2013
Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switchingDaniel S Widmer, Keith S Hoek, Phil F Cheng, et al.
Cancers|February 11, 2023
P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant MelanomaIshani Banik, Adhideb Ghosh, Erin Beebe, et al.
Nature Communications|October 14, 2023
Androgen receptor is a determinant of melanoma targeted drug resistanceAnastasia Samarkina, Markus Kirolos Youssef, Paola Ostano, et al.
Science (New York, N.Y.)|April 21, 2007
An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plantsHongchang Cui, Mitchell P Levesque, Teva Vernoux, et al.
The Journal of Clinical Investigation|May 1, 2019
SMAD signaling promotes melanoma metastasis independently of phenotype switchingEylul Tuncer, Raquel R Calçada, Daniel Zingg, et al.
Pageof 21